Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mixed lineage kinase 3
(
MLK3
) is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates multiple mitogen-activated protein kinase (MAPK) pathways in response to growth factors, stresses and the pro-inflammatory cytokine, tumor necrosis factor (TNF).
MLK3
is required for optimal activation of stress activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling by TNF, however, the mechanism by which
MLK3
is recruited and activated by the TNF receptor remains poorly understood. Here we report that both TNF and interleukin-1 beta (IL-1 beta) stimulation rapidly activate
MLK3
kinase activity. We observed that TNF stimulates an interaction between
MLK3
and TNF receptor associated factor (TRAF) 2 and IL-1 beta stimulates an interaction between
MLK3
and TRAF6. RNA interference (RNAi) of traf2 or traf6 dramatically impairs
MLK3
activation by TNF indicating that TRAF2 and TRAF6 are critically required for
MLK3
activation. We show that TNF also stimulates ubiquitination of
MLK3
and
MLK3
can be conjugated with lysine 48 (K48)- and lysine 63 (K63)-linked
polyubiquitin
chains. Our results suggest that K48-linked ubiquitination directs
MLK3
for proteosomal degradation while K63-linked ubiquitination is important for
MLK3
kinase activity. These results reveal a novel mechanism for
MLK3
activation by the pro-inflammatory cytokines TNF and IL-1 beta.
...
PMID:Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. 1958 14